BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 26700229)

  • 1. Topical Amphotericin B solid lipid nanoparticles: Design and development.
    Butani D; Yewale C; Misra A
    Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
    Jansook P; Fülöp Z; Ritthidej GC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles.
    Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Gill P; Valizadeh H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2015 Apr; 128():473-479. PubMed ID: 25797482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.
    Bhalekar MR; Pokharkar V; Madgulkar A; Patil N; Patil N
    AAPS PharmSciTech; 2009; 10(1):289-96. PubMed ID: 19294517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
    Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
    Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.
    Vaghasiya H; Kumar A; Sawant K
    Eur J Pharm Sci; 2013 May; 49(2):311-22. PubMed ID: 23557842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
    Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR
    Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M; Nazemiyeh H
    Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retinyl palmitate-loaded solid lipid nanoparticle system: effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo.
    Jeon HS; Seo JE; Kim MS; Kang MH; Oh DH; Jeon SO; Seong Hoon Jeong ; Choi YW; Lee S
    Int J Pharm; 2013 Aug; 452(1-2):311-20. PubMed ID: 23702002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
    Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
    Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.